GT Medical Technologies, Inc.

📍 Tempe, United States🗓 Founded 2017👥 99 employees💰 Last funded Dec 2024
GT Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care. GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile provides immediate, localized treatment. This approach targets remaining cancer cells when they are at their lowest levels to help prevent regrowth, while minimizing radiation exposure to healthy brain tissue.(1) Since its full market launch in the United States in March 2020, GammaTile has been adopted by more than 100 leading centers, underscoring its growing acceptance in both academic and community healthcare settings. For more information, visit gammatile.com. Reference: 1. Garcia MA et al. J Neurooncol. 166:203-212 (2024).
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2017
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in GT Medical Technologies, Inc.?
GT Medical Technologies, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did GT Medical Technologies, Inc. last raise funding?
The most recent investment in GT Medical Technologies, Inc. recorded on gritt.io was in December 2024.
When was GT Medical Technologies, Inc. founded?
GT Medical Technologies, Inc. was founded in 2017.
What industry is GT Medical Technologies, Inc. in?
GT Medical Technologies, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is GT Medical Technologies, Inc. based?
GT Medical Technologies, Inc. is headquartered in Tempe, United States.